These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 29191739)
1. Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection. Galvez-Romero G; Salas-Rojas M; Pompa-Mera EN; Chávez-Rueda K; Aguilar-Setién Á Vaccine; 2018 Jan; 36(2):292-298. PubMed ID: 29191739 [TBL] [Abstract][Full Text] [Related]
2. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus. Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant activity of PCP-II, a polysaccharide from Poria cocos, on a whole killed rabies vaccine. Zhang W; Cheng N; Wang Y; Zheng X; Zhao Y; Wang H; Wang C; Han Q; Gao Y; Shan J; Yang S; Xia X Virus Res; 2019 Sep; 270():197638. PubMed ID: 31173772 [TBL] [Abstract][Full Text] [Related]
4. Immunoenhancement with flagellin as an adjuvant to whole-killed rabies vaccine in mice. Xiao XX; Zhang Y; Liu JX; Wei QL; Yin XP Arch Virol; 2016 Mar; 161(3):685-91. PubMed ID: 26650039 [TBL] [Abstract][Full Text] [Related]
5. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice. Kaur M; Saxena A; Rai A; Bhatnagar R FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168 [TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine. Luo J; Zhang B; Wu Y; Tian Q; Zhao J; Lyu Z; Zhang Q; Mei M; Luo Y; Guo X Vaccine; 2017 Feb; 35(6):938-944. PubMed ID: 28089546 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of Interleukin-7 Extends the Humoral Immune Response Induced by Rabies Vaccination. Li Y; Zhou M; Luo Z; Zhang Y; Cui M; Chen H; Fu ZF; Zhao L J Virol; 2017 Apr; 91(7):. PubMed ID: 28100620 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB/c mice. Hu X; Liu R; Zhu N Immunobiology; 2013 Dec; 218(12):1524-8. PubMed ID: 23816301 [TBL] [Abstract][Full Text] [Related]
9. Rabies DNA vaccination by the intranasal route in dogs. Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480 [TBL] [Abstract][Full Text] [Related]
10. Alum adjuvanted rabies DNA vaccine confers 80% protection against lethal 50 LD Garg R; Kaur M; Saxena A; Prasad R; Bhatnagar R Mol Immunol; 2017 May; 85():166-173. PubMed ID: 28267643 [TBL] [Abstract][Full Text] [Related]
11. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein. Amann R; Rohde J; Wulle U; Conlee D; Raue R; Martinon O; Rziha HJ J Virol; 2013 Feb; 87(3):1618-30. PubMed ID: 23175365 [TBL] [Abstract][Full Text] [Related]
12. A Novel Rabies Vaccine Expressing CXCL13 Enhances Humoral Immunity by Recruiting both T Follicular Helper and Germinal Center B Cells. Wang Z; Li M; Zhou M; Zhang Y; Yang J; Cao Y; Wang K; Cui M; Chen H; Fu ZF; Zhao L J Virol; 2017 Feb; 91(3):. PubMed ID: 27852854 [TBL] [Abstract][Full Text] [Related]
13. AAV-expressed G protein induces robust humoral and cellular immune response and provides durable protection from rabies virus challenges in mice. Liu C; Li J; Yao Q; Gao Z; Cheng Y; Zhou M; Tang Y; Sun L; Dai J; Cao G; Zhang XL; Zhang R Vet Microbiol; 2020 Mar; 242():108578. PubMed ID: 32122589 [TBL] [Abstract][Full Text] [Related]
14. Sindbis virus replicon-based DNA vaccine encoding Rabies virus glycoprotein elicits specific humoral and cellular immune response in dogs. Gupta PK; Dahiya SS; Kumar P; Rai A; Patel CL; Sonwane AA; Saini M Acta Virol; 2009; 53(2):83-8. PubMed ID: 19537908 [TBL] [Abstract][Full Text] [Related]
15. Enhanced Immune Response to Rabies Viruses by the Use of a Liposome Adjuvant in Vaccines. Miao L; Yang Y; Yan M; Li Y; Zhao J; Guo J; Zheng D Viral Immunol; 2017 Dec; 30(10):727-733. PubMed ID: 28953450 [TBL] [Abstract][Full Text] [Related]
16. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination. Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of multi-epitope-based vaccine candidates administered with the adjuvant Gp96 against rabies. Niu Y; Liu Y; Yang L; Qu H; Zhao J; Hu R; Li J; Liu W Virol Sin; 2016 Apr; 31(2):168-75. PubMed ID: 27068655 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus. Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096 [TBL] [Abstract][Full Text] [Related]
19. Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus. Zhang D; Xia Q; Wu J; Liu D; Wang X; Niu Z Vaccine; 2011 Jan; 29(4):629-35. PubMed ID: 21134449 [TBL] [Abstract][Full Text] [Related]
20. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice. Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]